Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models

Despite substantial improvements in the treatment strategies, ovarian cancer is still the most lethal gynecological malignancy. Identification of drug treatable therapeutic targets and their safe and effective targeting is critical to improve patient survival in ovarian cancer. AXL receptor tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanlikilicer, Pinar, Ozpolat, Bulent, Aslan, Burcu, Bayraktar, Recep, Gurbuz, Nilgun, Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Denizli, Merve, Gonzalez-Villasana, Vianey, Ivan, Cristina, Lokesh, Ganesh L.R., Amero, Paola, Catuogno, Silvia, Haemmerle, Monika, Wu, Sherry Yen-Yao, Mitra, Rahul, Gorenstein, David G., Volk, David E., de Franciscis, Vittorio, Sood, Anil K., Lopez-Berestein, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675720/
https://www.ncbi.nlm.nih.gov/pubmed/29246304
http://dx.doi.org/10.1016/j.omtn.2017.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675720/
https://www.ncbi.nlm.nih.gov/pubmed/29246304
http://dx.doi.org/10.1016/j.omtn.2017.06.023

Ejemplares similares